|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Operating lease right-of-use assets amortization expense | |||||
| Bad debt expense (recovery) | |||||
| Deferred taxes | |||||
| Stock-based compensation expense | |||||
| Unrealized gain on derivative instruments | |||||
| Impairment charges | |||||
| Loss on sale of business | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Trade receivables and contract assets | |||||
| Prepaid and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Income taxes payable | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of short-term investments | |||||
| Proceeds from short-term investments | |||||
| Acquisition of businesses, net of cash acquired (Note 3) | |||||
| Cash sold as part of sale of business, net of proceeds | |||||
| Purchases of non-marketable securities | |||||
| Proceeds from sale of non-marketable securities | |||||
| Other investing activities, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of stock under employee incentive programs | |||||
| Payments of withholding taxes related to net share settlements of equity awards | |||||
| Proceeds from debt | |||||
| Repayment of debt | |||||
| Repurchase of common stock | |||||
| Payment of contingent consideration for previously acquired businesses | |||||
| Purchase of subsidiary shares from noncontrolling interest | |||||
| Payment of deferred consideration for asset acquisitions | |||||
| Other financing activities, net | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the year for: | |||||
| Income taxes, net of refunds | |||||
| Interest | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Acquisition-date fair value of contingent consideration issued for acquisition of businesses | |||||
| Capital expenditures incurred but not yet paid |
Loading...